TET3-Mediated m5C Modification of CCAT2 Accelerates Cardiac Microvascular Endothelial Cell Damage in Acute Coronary Syndrome.

Saved in:
Bibliographic Details
Title: TET3-Mediated m5C Modification of CCAT2 Accelerates Cardiac Microvascular Endothelial Cell Damage in Acute Coronary Syndrome.
Authors: Liu JC; Department of Cardiology, Henan Province People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.; National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Central China Subcenter of National Center for Cardiovascular Diseases, Henan Cardiovascular Disease Center, Fuwai Central-China Cardiovascular Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, China.; Henan Provincial Cell and Gene Engineering Technology Research Center for Cardiovascular Disease, Fuwai Central-China Cardiovascular Hospital, Zhengzhou, China., Wang WJ; National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Central China Subcenter of National Center for Cardiovascular Diseases, Henan Cardiovascular Disease Center, Fuwai Central-China Cardiovascular Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, China.; Henan Provincial Cell and Gene Engineering Technology Research Center for Cardiovascular Disease, Fuwai Central-China Cardiovascular Hospital, Zhengzhou, China., Zhang TT; Henan Provincial Cell and Gene Engineering Technology Research Center for Cardiovascular Disease, Fuwai Central-China Cardiovascular Hospital, Zhengzhou, China.; Center for Clinical Single-Cell Biomedicine, Henan Province People's Hospital, Zhengzhou, China., Yang QC; National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Central China Subcenter of National Center for Cardiovascular Diseases, Henan Cardiovascular Disease Center, Fuwai Central-China Cardiovascular Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, China.; Henan Provincial Cell and Gene Engineering Technology Research Center for Cardiovascular Disease, Fuwai Central-China Cardiovascular Hospital, Zhengzhou, China., Dilimulati H; Department of Cardiology, Henan Province People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.; National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Central China Subcenter of National Center for Cardiovascular Diseases, Henan Cardiovascular Disease Center, Fuwai Central-China Cardiovascular Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, China.; Henan Provincial Cell and Gene Engineering Technology Research Center for Cardiovascular Disease, Fuwai Central-China Cardiovascular Hospital, Zhengzhou, China., An ST; Department of Cardiology, Henan Province People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.; National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Central China Subcenter of National Center for Cardiovascular Diseases, Henan Cardiovascular Disease Center, Fuwai Central-China Cardiovascular Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, China.; Henan Provincial Cell and Gene Engineering Technology Research Center for Cardiovascular Disease, Fuwai Central-China Cardiovascular Hospital, Zhengzhou, China.
Source: The Kaohsiung journal of medical sciences [Kaohsiung J Med Sci] 2026 May; Vol. 42 (5), pp. e70128. Date of Electronic Publication: 2025 Nov 29.
Publication Type: Journal Article
Journal Info: Publisher: Department of Public Health, Kaohsiung Medical University Country of Publication: China (Republic : 1949- ) NLM ID: 100960562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2410-8650 (Electronic) Linking ISSN: 1607551X NLM ISO Abbreviation: Kaohsiung J Med Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2410-8650
DOI:10.1002/kjm2.70128